We’re pioneering precision neurology by building the world’s leading platform for reliable, accessible, affordable diagnosis and monitoring of neurological diseases. At Altoida, we recognize the need for individuals to understand their brain health so they can make informed decisions on leading happy and healthy lifestyles. Built on more than two decades of research with global industry leaders and thousands of patients, our digital platform and augmented reality activities provide robust measurements of brain function across 13 unique neurocognitive domains, while our innovative artificial intelligence will power early Alzheimer’s disease identification.
“My grandmother was born in a small village in Greece. When she was 70 and I was pursuing my degree in psychology, she started to repeat her own words. Soon after, she started to become lost in her home, the place that she loved most. In the later stages of what we knew to be Alzheimer’s, she started to forget my father’s face. What struck me most was how in the early stages, I was able to recognize that something was wrong, yet she passed all of the traditional cognitive exams with ease.
This drove me to engineer a virtual environment to assess the changes in brain health, both cognitive and functional, that I observed firsthand with my grandmother. I learned that exercises in a virtual environment open up an entirely new horizon of more meaningful measurements and data that can be acquired. From there, we spent 20 years of research to bring us to where we are today.”
At Altoida, we provide digital biomarker technology that allows you to understand your brain health early to take the right next steps. Connect with our team today.
At Altoida, you will work with the world’s most passionate engineers and scientists with one common goal—creating a product that provides better brain health for all. We are always looking for innovative, out-of-the-box thinkers to join our diverse and collaborative team.
Our Altoida family is united by 5 core principles:
- We are data-first: Data isn’t a buzzword to us; it’s at the core of our technology and in the DNA of our decision-making processes.
- We are relentless: We know the impact our work will have on the world and are in pursuit of extremely lofty goals—we don't settle at “good enough.”
- We are innovative: Our founders, executives, and early team members are united by a love of thinking differently and seeing groundbreaking ideas come to life.
- We are thoughtful: From the way we treat each other to the way we unpack tough problems, we are considerate, respectful, and holistic.
- We are adaptive: In a high-tech world, nothing is set in stone—we recognize and embrace that in our strategy and culture.
Altoida is building the world's leading platform to accelerate and improve drug development, research, and care for people with neurological diseases using data captured with a standard smartphone or tablet
Conventional Biomarkers & Cognitive Assessments
Traditional neurological testing is highly subjective and relies on manual scoring and evaluation of symptoms.
Biomarkers evaluated through imaging and cerebrospinal fluid require costly capital equipment and clinical analyses.
Collection of biological samples and measurements of brain function require long in-person visits to clinical sites.
Altoida's Digital Biomarker Platform
Altoida’s platform extracts multi-modal data to provide the most sensitive measurements and digital biomarkers for neurological diseases.
The 10 minute neurological test battery and real-time analysis are completed using only a standard iOS or Android smartphone or tablet.
The platform can be used outside of clinical settings and is supported in a diverse variety of global languages.
Our AI-powered platform will enable reliable, accessible, and affordable diagnosis and monitoring of neurological diseases at every phase on the continuum